Human Breast Cancer Tissue Lysates

Pricing

Normal Lysates: $125/100 ug

Tumor Lysates: $175/100 ug

Nor./Tum. set: $270.00 (10% off)

Discounts

2-8 Vials 10%

9-20 Vials 15%

>20 Vials 20%

Introduction:

The following is a list of breast cancer histologic classifications. Infiltrating or invasive ductal cancer is the most common breast cancer histologic type and comprises 70% to 80% of all cases.

Carcinoma, NOS (not otherwise specified).

Ductal - Intraductal (in situ), Invasive with predominant Intraductal component, Invasive, NOS, Comedo (Inflammatory, Medullary with lymphocytic infiltrate, Mucinous (colloid), Papillary, Scirrhous, Tubular, Other).

Lobular - In situ, Invasive with predominant in situ component, Invasive.

Nipple - Paget�s disease, Paget�s disease with intraductal carcinoma, Paget�s disease with invasive ductal carcinoma.

Other - Undifferentiated carcinoma.

The following are tumor subtypes that occur in the breast but are not considered to be typical breast cancers - Cystosarcoma phyllodes, Angiosarcoma, Primary lymphoma.

Human Breast Cancer Tissue Lysates
Catalog Number	Diagnosis	Grade	Stage	TNM	Sex	Age
T2-001	Ductal Carcinoma	2	IIA	T2N0M0	F	54
T2-002	Ductal Carcinoma	2	IIIB	T2N1M0	F	36
T2-003	Ductal Carcinoma	2	IV	T4N2Mx	F	61
T2-004	Ductal Carcinoma	2	II	T2N0Mx	F	72
T2-005	Ductal Carcinoma	2	IV	T4N2Mx	F	45
T2-006	Ductal Carcinoma	2	IIA	T2N0M0	F	42
T2-007	Ductal Carcinoma	2	IIB	T2N1M0	F	44
T2-008	Ductal Carcinoma	2	IIB	T2N1M0	F	39
T2-009	Ductal Carcinoma	2	IIIB	T4bN1M0	F	54
T2-010	Ductal Carcinoma	2	IIB	T2N1M0	F	54
T2-011	Ductal Carcinoma	2	IIB	T3N0M0	F	46
T2-012	Ductal Carcinoma	2	IIIB	T4bN2M0	F	55
T2-013	Ductal Carcinoma	2	IIB	T2N1M0	F	44
T2-014	Ductal Carcinoma	2	IIB	T2N1M0	F	63
T2-015	Ductal Carcinoma	2	IIB	T2N1M0	F	61
T2-016	Ductal Carcinoma	2	IIA	T1N1M0	F	61
T2-017	Ductal Carcinoma	2	IV	T4N1Mx	F	85
T2-018	Ductal Carcinoma	2	IV	T4N0M0	F	75
T2-019	Ductal Carcinoma	2	II	T2NxMx	F	47
T2-020	Ductal Carcinoma	3	IIA	T2N0M0	F	43
T2-021	Ductal Carcinoma	3	IIB	T2N1M0	F	61
T2-022	Ductal Carcinoma	3	IIB	T2N1M0	F	39
T2-023	Ductal Carcinoma	3	II	T2N1Mx	F	35
T2-024	Ductal Carcinoma	3	III	T3N1bMx	F	73
T2-025	Ductal Carcinoma	3	IIB	T2N1M0	F	50
T2-026	Ductal Carcinoma	3	IIIA	T3N1M0	F	52
T2-027	Ductal Carcinoma	3	IIIA	T3N1M0	F	49
T2-028	Ductal Carcinoma	3	II	T2NxM0	F	41
T2-029	Ductal Carcinoma	3	IV	T4N1M0	F	47
T2-030	Ductal Carcinoma	3	II	T2N1M0	F	55
T2-031	Ductal Carcinoma	3	II	T2N0M0	F	75
T2-032	Ductal Carcinoma	3	II	T2N1M0	F	53
T2-033	Ductal Carcinoma	3	II	T2N1M0	F	60
T2-034	Ductal Carcinoma	3	IV	T4N2Mx	F	54
T2-035	Ductal Carcinoma	3	II	T2N1M0	F	43
T2-036	Ductal Carcinoma	3	II	T2N1Mx	F	53
T2-037	Ductal Carcinoma	3	III	T3N2M0	F	43
T2-038	Ductal Carcinoma	3	II	T2N1M0	F	58
T2-039	Mucinous Carcinoma	1	II	T2N1Mx	F	51
T2-040	Ductal Carcinoma	2	IIIB	T4bN2M0	F	48
T2-041	Ductal Carcinoma	2	IIIA	T3N2M0	F	42
T2-042	Ductal Carcinoma	2	II	T2NxM0	F	37
T2-043	Ductal Carcinoma	1	IIB	T2N1M0	F	51
T2-044	Ductal Carcinoma	1	IIIA	T3N1M0	F	47
T2-045	Ductal Carcinoma	1	IIIA	T3N1M0	F	38
T2-046	Ductal Carcinoma	1	IIA	T2N0M0	F	60
T2-047	Ductal Carcinoma	2	IIB	T2N1M0	F	32
T2-048	Ductal Carcinoma	1	IIB	T2N1M0	F	39
T2-049	Mucinous Carcinoma	2	IIIA	T3N1M0	F	43
T2-050	Lobular Carcinoma	n/a	III	T3N2M0	F	39
T2-051	Ductal Carcinoma	3	III	T3N2M0	F	44
T2-052	Mucinous Carcinoma	n/a	IB	T2N0Mx	F	59
T2-053	Metaplastic Carcinoma	3	IV	T4N1bMx	F	46
T2-054	Intraductal Carcinoma	2	IIA	T2N0M0	F	41
T2-055	Intraductal Carcinoma	2	IIB	T2N1M0	F	40
T2-056	Intraductal Carcinoma	2	IIA	T2N0M0	F	50

References:

Breast. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002., pp 171-180.

Yeatman TJ, Cantor AB, Smith TJ, et al.: Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222 (4): 549-59; discussion 559-61, 1995.

Chaney AW, Pollack A, McNeese MD, et al.: Primary treatment of Cystosarcoma phyllodes of the breast. Cancer 89 (7): 1502-11, 2000.